Mosaic ImmunoEngineering (CPMV) Long-Term Investments (2011 - 2020)
Mosaic ImmunoEngineering (CPMV) posted quarterly Long-Term Investments of $27590.0 for Q4 2020, down 60.06% year-over-year from $69084.0 in Q4 2019, and down 3.64% quarter-over-quarter from $28632.0 in Q3 2020.
Mosaic ImmunoEngineering (CPMV) Long-Term Investments (2011 - 2020) Analysis & Trends
Mosaic ImmunoEngineering's Long-Term Investments history runs 10 years deep, the most recent figure standing at $27590.0 for Q4 2020.
- In Q4 2020, Long-Term Investments fell 60.06% year-over-year to $27590.0; the TTM figure through Nov 2020 stood at $27590.0 (down 60.06% YoY), while the FY2020 annual figure was $27637.0, changed N/A from the prior year.
- Long-Term Investments for Q4 2020 stood at $27590.0, down from $28632.0 in the prior quarter.
- The five-year high for Long-Term Investments was $879978.0 in Q3 2017, with the low at $27590.0 in Q4 2020.
- The 5-year median for Long-Term Investments is $264977.0 (2016), against an average of $304894.0.
- The sharpest annual moves came in 2017 and 2020: Long-Term Investments surged 159.45% in 2017, then slumped 88.5% in 2020.
- Mosaic ImmunoEngineering's Long-Term Investments stood at $500409.0 in 2016, then surged by 34.84% to $674742.0 in 2017, then tumbled by 49.29% to $342133.0 in 2018, then tumbled by 79.81% to $69084.0 in 2019, then plunged by 60.06% to $27590.0 in 2020.
- Business Quant data shows CPMV's Long-Term Investments at $27590.0 in Q4 2020, $28632.0 in Q3 2020, and $34403.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2020 | 27,590.00 |
| Aug 31, 2020 | 28,632.00 |
| Feb 29, 2020 | 34,403.00 |
| Nov 30, 2019 | 69,084.00 |
| Aug 31, 2019 | 234,758.00 |
| May 31, 2019 | 107,861.00 |
| Feb 28, 2019 | 299,131.00 |
| Nov 30, 2018 | 342,133.00 |
| May 31, 2018 | 199,373.00 |
| Feb 28, 2018 | 279,354.00 |
| Nov 30, 2017 | 674,742.00 |
| Aug 31, 2017 | 879,978.00 |
| May 31, 2017 | 441,988.00 |
| Feb 28, 2017 | 446,503.00 |
| Nov 30, 2016 | 500,409.00 |
| Aug 31, 2016 | 501,196.00 |
| May 31, 2016 | 170,357.00 |
| Feb 29, 2016 | 250,600.00 |
| Nov 30, 2015 | 1.03 Mn |
| Aug 31, 2015 | 236,917.00 |